Clinical trial
IUdR/BUdR Cell Cycle Labelling
NCT00042250 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00042250 |
|---|---|
| Title | IUdR/BUdR Cell Cycle Labelling |
| Official title | Cell Cycle Kinetics in Vivo in Patients With Hematologic Malignancies Studied by Iododeoxyuridine and Bromodeoxyuridine Labelling |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Hematologic Malignancies |
| Intervention type | Drug |
| Interventions | Chemotherapy for hematologic malignancy |
| Enrollment | 28 |
| Start date | May 1, 1992 |
| Primary completion | Oct 1, 2002 |
| Completion | Oct 1, 2002 |
| First posted | Jul 26, 2002 |
| Last update posted | Jan 24, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: